Metabolomics Workbench : NIH Data Repository

Lipid composition heatmap for Study ST002958

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.

Group A	Combined factors (this analysis)	Group B
	Tissue:Brain \| Genotype:N/A \| Timepoint:N/A \| Treatment:N/A
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Brain \| Genotype:- \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Brain \| Genotype:- \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Brain \| Genotype:- \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Brain \| Genotype:- \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 24 \| Treatment:Control
	Tissue:Brain \| Genotype:- \| Timepoint:Week 24 \| Treatment:Control
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 6 \| Treatment:Control
	Tissue:Brain \| Genotype:- \| Timepoint:Week 6 \| Treatment:Control
	Tissue:N/A \| Genotype:N/A \| Timepoint:N/A \| Treatment:N/A
	Tissue:Serum \| Genotype:N/A \| Timepoint:N/A \| Treatment:N/A
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Serum \| Genotype:- \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Serum \| Genotype:- \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Serum \| Genotype:- \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Serum \| Genotype:- \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 6 \| Treatment:Control
	Tissue:Serum \| Genotype:- \| Timepoint:Week 6 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:N/A \| Timepoint:N/A \| Treatment:N/A
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 24 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 24 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 6 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 6 \| Treatment:Control
Select a lipid RefMet sub class:

Lipid sub classes in this study	Number in study
LPC	14
LPE	13
O-PC	27
O-PE	27
O-PS	16
PA	22
PC	53
PE	53
PI	26
PS	48
SM	12

Group A	Combined factors (this analysis)	Group B
	Tissue:Brain \| Genotype:N/A \| Timepoint:N/A \| Treatment:N/A
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Brain \| Genotype:- \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Brain \| Genotype:- \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Brain \| Genotype:- \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Brain \| Genotype:- \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 24 \| Treatment:Control
	Tissue:Brain \| Genotype:- \| Timepoint:Week 24 \| Treatment:Control
	Tissue:Brain \| Genotype:+ \| Timepoint:Week 6 \| Treatment:Control
	Tissue:Brain \| Genotype:- \| Timepoint:Week 6 \| Treatment:Control
	Tissue:N/A \| Genotype:N/A \| Timepoint:N/A \| Treatment:N/A
	Tissue:Serum \| Genotype:N/A \| Timepoint:N/A \| Treatment:N/A
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Serum \| Genotype:- \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Serum \| Genotype:- \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Serum \| Genotype:- \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Serum \| Genotype:- \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Serum \| Genotype:+ \| Timepoint:Week 6 \| Treatment:Control
	Tissue:Serum \| Genotype:- \| Timepoint:Week 6 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:N/A \| Timepoint:N/A \| Treatment:N/A
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 12 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 12 \| Treatment:SobAM2
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 18 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 18 \| Treatment:SobAM2
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 24 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 24 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:+ \| Timepoint:Week 6 \| Treatment:Control
	Tissue:Spinal cord \| Genotype:- \| Timepoint:Week 6 \| Treatment:Control
Select a lipid RefMet sub class: